Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype. (Q39293549)
Jump to navigation
Jump to search
scientific article published on 21 August 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype. |
scientific article published on 21 August 2012 |
Statements
Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype (English)
Paymaneh D Malihi
Yuqiu Jiang
Haiying Wang
Yixin Wang
Daniel L Ruderman
21 August 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference